EICHORCondition: Quality of Life · Depression · End Stage Renal Disease · Sponsor: Johns Hopkins University
Interested? Contact the study team ↓
The purpose of this mixed methods study is to adapt CAPABLE as CAPABLE Transplant to accomplish two things: 1) To resolve barriers to being classified as active on the Kidney Transplant (KT) waitlist, 2) as a surgical prehabilitation intervention targeting the pre-frail/ frail KT waitlist population. It consists of two phases- an open label pilot and a randomized waitlist control trial, and 3) pilot test the feasibility and acceptability for CAPABLE Transplant in symptom and waitlist specific metrics amongst low-income active kidney transplant waitlist candidates.
This description comes directly from the study's public registry record.
Melissa Hladek, PhD · 4106142418 · mhladek1@jh.edu
Meagan Clemence, MS · 410-705-5808 · mcleme26@jh.edu
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Deceased Donor Waitlist * ≥18 years old * Community dwelling * Current Inactive status or active and had been inactive in the last 18 months for cardiovascular disease, frailty, obesity, social support, mental health, incomplete testing OR Active on the waitlist and low-income Exclusion Criteria: * Living Donor Waitlist * Severe cognitive impairment * Inactivity expected to last \> 3 months (eg cancer treatment) * \>4 hospitalizations in the last 12 months * Current home nursing, physical or occupational therapy
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Johns Hopkins School of Nursing | Baltimore, Maryland, United States | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06326905